Lorlatinib is a third-generation inhibitor for ALK and ROS1, used for ALK-positive NSCLC that’s spread to other parts of the body. It’s for people who’ve tried other ALK inhibitors and their cancer got worse. It specifically targets the ALK and ROS1 kinases, which are really important in making tumors grow.
You can get Lorlatinib in two strengths: 25 mg and 100 mg, in those coated tablets. You’re supposed to take 100 mg a day, and it doesn’t matter if you take it with or without food. Each pack comes with 30 tablets, so you can easily keep track of your medicine.
